Looks like the horrible Shkreli, who I think of as Shrek-li, was short AVXL, or wants to buy a lot of AVXL cheap. He claims that based on reading the abstract, Anavex "can't" work.

Uh-huh. This from the guy who thinks it's just fine to raise prices for a 50 year old drug from$13.50 to $750. The guy who "used to be" a notorious short seller. Or maybe he's back to his old short-selling ways now.

http://www.bloomberg.com/bw/articles/2014-04-...-went-long